Furthermore, our studies in the CAM model revealed that DJ-1 overexpression promoted angiogenesis of sorafenib-resistant HCC cells, but this phenotype could potentially be reversed by FGFR1 knockdown (Figure 7). This evidence concerns the gene PARK7 and hepatocellular carcinoma.